© 2022 HealthCom Media All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder.
Home 2011
Archives
FDA warning for terbutaline in preterm labor
The U.S. Food and Drug Administration issued a warning that terbutaline, indicated for asthma, bronchitis, and emphysema, should not be used in pregnant women...
FDA approves drug to reduce risk of preterm birth
The U.S. Food and Drug Administration (FDA) has approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery in pregnant women with...
Baby deliveries scheduled too soon, says new Leapfrog report
The Leapfrog Group has released a new report stating that thousands of babies are electively scheduled for delivery too early, resulting in a higher...
FDA advises women with breast impants
The U.S. Food and Drug Administration says women with breast implants may have a “very small, but increased risk” of developing anaplastic large cell...
Do you know which vaccines are recommended for special populations?
Pregnant and postpartum women, immunocompromised
children, and persons at high risk for flu-related complications have special immunization needs. Part of ANA’s Bringing
Immunity to Every Community campaign, this handout
explains how to help ensure that these vulnerable populations are protected.
FDA recommends removing Avastin’s breast cancer indication
The U.S. Food and Drug Administration (FDA) is recommending that the breast cancer indication for Avastin be removed from its label “because the drug...
Pregnant women and drug trials
Read a thoughtful essay from Melinda Wenner Moyer on clinical trials in women who are pregnant: http://blogs.plos.org/bodypolitic/2011/01/06/why-pregnant-women-deserve-drug-trials/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+plos%2Fblogs%2Fmain+%28Blogs+-+Main%29.
Postpartum depression: Don’t let patients suffer in silence
This might come as a surprise, but postpartum depression (PPD) is the number-one complication of childbearing. Experts estimate it strikes at least one in...
What every nurse needs to know about breast cancer
Breast cancer strikes 1 in 8 American women. This article discusses recent diagnostic and treatment advances (including some you may not know about) that may brighten the outlook for the nearly 180,000 American women diagnosed with the disease each year.
Polycystic ovary syndrome: A threat to appearance, menstruation, and fertility
Affecting 1 in 10 U.S. females, this distressing condition can be treated, though not cured. Your compassionate care and on-point teaching can make a big difference to patients.
Risks pf BSGI and PEM studies
According to a study in Radiology, a single breast-specific gamma imaging (BSGI) or positron emission mammography (PEM) test is “associated with a fatal radiation-induced...
Avastin may lose metastatic breast cancer indication
An U.S. Food and Drug Administration (FDA)-advisory panel has voted to strip Avastin’s indication for metastatic breast cancer because the drug is not effective...
In some situations, axillary node removal doesn’t improve breast cancer survival
A study presented at the American Society of Clinical Oncology June meeting found that removing additional axillary lymph nodes to look for breast cancer...
FDA approves new drug for osteoporosis
On June 1, the U.S. Food and Drug Administration (FDA) approved Prolia (denosumab), an injectable treatment for postmenopausal women with osteoporosis who are at...
Birth control pill most popular form of contraception in U.S.
Results from in-person interviews of women found that during 2006-2008 the most popular form of contraception in the U.S. was the oral contraception pill,...
Women of child-bearing age more likely to survive cardiac arrest compared to men
Women of child-bearing age more likely to survive cardiac arrest compared to men
According to a study in the May issue of Critical Care Medicine,...
Intraperitoneal chemotherapy: Improving the odds for ovarian cancer patients
Patients with ovarian cancer may receive intraperitoneal (IP) chemotherapy, which delivers chemotherapeutic agents directly into the peritoneal cavity. Drugs given by this route include paclitaxel, carboplatin, and cisplatin.
Vitamin C and E don’t prevent complications of pregnancy-associated hypertension
According to a report in the New England Journal of Medicine, vitamin C and E supplements failed to decrease the rate of adverse maternal...
Pregestational diabetes associated with congenital anomalies
Pregestational diabetes is associated with congenital anomalies, but obesity alone is not, according to a study in the Obstetrics and Gynecology. However, obesity predisposes...
March of Dimes releases new nursing education modules
The March of Dimes has released three new nursing education modules:
Diabetes in Pregnancy, 4th Edition;
Genetic Issues for Perinatal Nurses, 3rd Edition; and
Preterm Infants: Transition...
Drug approval for breast cancer
The U.S. Food and Drug Administration has approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer...
Drugs Today – July/August 2009
A weekly update of drug news, including alerts, approvals, and removals.
Health Network Strives for Excellence in Women’s Health Care
In 1996, a group of physicians, nurses, and healthcare consumers were sitting around a kitchen table in Allentown, Pennsylvania, discussing what keeps women from getting needed health care.
Take Note – April 2009
A monthly round-up of clinical and practice news and alerts.
Ending the cycle
Nurses nationwide work to eliminate partner violence.
Sexuality assessment and intervention tool
Web exclusive!
Drugs Today – October 2008
Web Exclusive! An update of drug news, including alerts, approvals, and removals.
Sex after breast cancer: Helping your patient cope
Sexual dysfunction plagues many breast cancer patients. Learn why this happens and how to intervene appropriately.
Take Note – September 2008
Johnson & Johnson’s Campaign for Nursing’s Future
In 2002, Johnson & Johnson launched the Campaign for Nursing’s Future to enhance the image of nursing, help...
Take Note – July 2008
Measles outbreak
Between January 1 and April 25, the Centers for Disease Control and Prevention received reports of 64 measles cases in nine states—the highest...
Drugs Today – July 2008
An update of drug news, including alerts, approvals, and removals.
Q&A with the Executive Director of AWHONN
In May, we celebrate Nurses’ Week, Women’s Health Week, and Mother’s Day. In the spirit of these celebrations, we asked Joseph C. Isaacs, CAE,...
Stopping the silent progression of osteoporosis
An update on risk factors, prevention, and treatment.
Take Note – April 2008
Pam Cipriano to receive ANA’s Distinguished Member Award
American Nurse Today Editor-in-Chief Pamela Cipriano, PhD, RN, FAAN, will receive the Distinguished Member Award from the...
Preeclampsia: The little-known truth
The risks associated with preeclampsia don't end when the newborn is delivered.
Helping homeless pregnant women: A lesson in hope
For some pregnant women, being home for the holidays means staying at a homeless shelter.